2007
DOI: 10.1007/s00253-006-0652-7
|View full text |Cite
|
Sign up to set email alerts
|

Cooverexpression of chaperones for enhanced secretion of a single-chain antibody fragment in Pichia pastoris

Abstract: In Pichia pastoris, secretion of the A33 single-chain antibody fragment (A33scFv) was shown to reach levels of approximately 4 g l(-1) in fermentor cultures. In this study, we investigated whether manipulating chaperone and foldase levels in P. pastoris could further increase secretion of A33scFv. Cells were engineered to cooverexpress immunoglobulin binding protein (BiP) and/or protein disulfide isomerase (PDI) with A33scFv during growth in methanol as the sole carbon and energy source. Cooverexpression of Bi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
69
1

Year Published

2007
2007
2017
2017

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 126 publications
(72 citation statements)
references
References 42 publications
2
69
1
Order By: Relevance
“…Then Potgieter et al (2009) presented the production of more than 1 g L À1 of a functional, full length antibody by a glycoengineered yeast strain in a robust, scaleable cultivation process with uniform N-linked glycans. However, for antibody fragments, expression levels in excess of 8 g L À1 have been achieved in P. pastoris (Damasceno et al, 2007) using a combination of strain improvements and process optimization techniques. Strain improvements included (i) co-expression of folding chaperones (Damasceno et al, 2007) such as immunoglobulin binding protein (BiP) and protein disulfide isomerase (PDI), (ii) protease deletions (Brankamp et al, 1995), (iii) optimization of secretion leaders , and (iv) the use of fusion proteins (Reitinger et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…Then Potgieter et al (2009) presented the production of more than 1 g L À1 of a functional, full length antibody by a glycoengineered yeast strain in a robust, scaleable cultivation process with uniform N-linked glycans. However, for antibody fragments, expression levels in excess of 8 g L À1 have been achieved in P. pastoris (Damasceno et al, 2007) using a combination of strain improvements and process optimization techniques. Strain improvements included (i) co-expression of folding chaperones (Damasceno et al, 2007) such as immunoglobulin binding protein (BiP) and protein disulfide isomerase (PDI), (ii) protease deletions (Brankamp et al, 1995), (iii) optimization of secretion leaders , and (iv) the use of fusion proteins (Reitinger et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…To attain this goal, the introduction of chaperones may improve the assembly of the antibody in the ER, resulting in efficient secretion. However, introduction of the chaperones was not sufficient to yield high amounts of full-length antibody in yeast, while the overexpression of chaperones such as disulfide isomerase have been reported to contribute partially to the enhancement of the secretability of the antibody fragment (8,14,36). In contrast, an increase in secretion was confirmed with several kinds of different antibodies by the addition of R3AD to O. minuta cultures (data not shown).…”
Section: Discussionmentioning
confidence: 65%
“…In eukaryotic cells the focus has been more on the ability of chaperones to reduce the cell toxicity of polyQ and asynuclein aggregates linked with the occurrence of neurodegenerative diseases such as Huntington and Parkinson (Auluck et al, 2002;Cummings et al, 2001;Muchowski and Wacker, 2005;Willingham et al, 2003). Fewer studies (Damasceno et al, 2007;Gasser et al, 2007;Smales et al, 2004) have examined the consequences of manipulation of the chaperone network in the context of recombinant protein production in cultured cell lines.…”
Section: Introductionmentioning
confidence: 97%